YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[mrna Cancer Vaccine] wildpixel/iStock via Getty Images INVESTORS SHOULD KNOW: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma into a broader test across harder-to-treat solid tumors. The…
[View of Moderna office entrance with logo sign, Biotechnology industry] Veronique D Shares of Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) have rallied 202% since Aug. 18, fueled by positive news about the biotech company's exper…
The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) closed in the green on Friday, after the week saw latest payroll data and ea…
Gilead shares are up 35% since Barron’s highlighted them, but our catalysts have yet to fully play out. Continue Reading
Investing.com -- B. Riley analyst Mayank Mamtani has identified top biotech picks heading into third-quarter 2026 earnings season, following the Federal Reserve's 25 basis point rate hike to 4.00%, its first increase since July 2023. The u…
Morgan Stanley highlights high-risk, high-reward biotech stocks poised for massive upside following key upcoming clinical readouts. Continue Reading
Morgan Stanley highlights high-risk, high-reward biotech stocks poised for massive upside following key upcoming clinical readouts. Continue Reading
Incyte Corp_ office sign-by Bo Shen via iStock Based in Wilmington, Delaware, Incyte Corporation (INCY) is a global biopharmaceutical company that discovers, develops, and commercializes innovative treatments for cancer, blood disorders, a…
The Vanguard Health Care ETF (NYSEMKT:VHT) offers broad sector exposure and lower fees, while the State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides a concentrated, more volatile play on the biotechnology subsector. Investors looking…
[Scientists inside a laboratory] Hinterhaus Productions The Food and Drug Administration and Duke-Margolis Institute for Health Policy will convene a public workshop this month to examine one of the most difficult questions in rare disease…
The Dow Jones index drops on the stock market today as yields and oil spike. Nvidia rises. Bitcoin and crypto stocks fall ahead of a key vote. Continue Reading
Stock Market Today: The Dow Jones index drops Tuesday as the 10-year Treasury yield reaches its highest level since 2007. Nvidia stock rises. Continue Reading
etf.com Top 10 Creations (All ETFs) Ticker Name Net Flows ($, mm) AUM ($, mm) AUM % Change VOO Vanguard S&P 500 ETF 3,535.26 1,067,456.75 0.33% QQQ Invesco QQQ Trust Series I 1,324.94 483,030.97 0.27% IEFA iShares Core MSCI EAFE ETF 596.75…
Quick Read Moderna surges 8% while cancer-vaccine partner Merck slips 0.3% and peer BioNTech gains just 0.5%, pointing to a Moderna-specific momentum or short-squeeze event. XBI falls 0.1% and SPY rises less than 1%, eliminating both secto…
Quick Read IBB surged 26% over three months versus SPY's 4%, as big pharma's price-insensitive buyouts of patent-cliff replacements rewarded IBB holders. XBI's equal-weight design returned 34% YTD versus IBB's 26%, making it the higher-tor…
Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built for investors. If a sector rallies in a forest and no one's there to hear it, does it really cash in? Moderna turned investors' heads a…
Merck MRK and Moderna MRNA delivered a significant breakthrough in melanoma treatment, with their jointly developed mRNA cancer vaccine showing positive results in its first-ever Phase 3 trial. This vaccine, combined with Merck's exemplary…
etf.com Top 10 Creations (All ETFs) Ticker Name Net Flows ($, mm) AUM ($, mm) AUM % Change QQQ Invesco QQQ Trust Series I 3,672.78 484,453.23 0.76% SMH VanEck Semiconductor ETF 1,394.20 66,206.23 2.11% SOXL Direxion Daily Semiconductor Bul…
Regeneron Pharmaceuticals logo is seen on a screen and a hand holding pills_ By Rafael Henrique Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company that turns cutting-edge science into medici…
Quick Read Moderna surged 11% while BioNTech gained just 2% on no catalyst, with MRNA's Reddit sentiment score of 88 flagging crowded retail positioning over fundamentals. BioNTech trails XBI's 3% session gain and its 35% YTD return, while…
The biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for the industry. While Moderna shares have remained volatile since then — down 23.5% Thur…
[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [http…
Biotech stocks had already been gaining ground before this week's news. In June, the iShares Nasdaq Biotechnology ETF (IBB) traded just 1.47% below its 52-week high after moving sideways since November. Then, Moderna (MRNA) surged more tha…
Wall Street’s major averages closed firmly higher on Friday, with Treasury yields largely steady and Bitcoin experiencing sharp intraday swings. The Dow Jones Industrial Average advanced 0.9%, the S&P 500 rose 0.4%, and the Nasdaq Composit…
[Patients Receiving Medical Infusions in a Clinical Setting with Nurse Assistance] FatCamera/iStock via Getty Images Earlier this week, shares of Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and partner Merck (MRK [https://seeking…
This article first appeared on GuruFocus. Bank of America is urging investors to look beyond some of 2026's most crowded market trades, highlighting contrarian opportunities across bonds, China, gold, artificial intelligence and the Novemb…
Investors are sensitive to any policy pronouncements from Federal Reserve Chairman Kevin Warsh (left) or Treasury Secretary Scott Bessent, as yields on long-term U.S. Treasury bonds rise. - MarketWatch photo illustration/Getty Images, iSto…
Biotech research by Gorodenkoff via Shutterstock Novavax (NVAX) is a biotechnology company headquartered in Gaithersburg, Maryland, focused on the discovery, development, and commercialization of vaccines that address serious infectious di…
Biotechnology Moderna's eye-popping surge on Wednesday didn't just reward holders of the stock. It supercharged what was already one of the strongest corners of the market this year: biotech and pharma. Moderna and Merck said their persona…
A bond market selloff has pressured 60/40 investment portfolios, which have returned 8% on average this year compared with 13% for the S&P 500. Investors can look to healthcare stocks for relief. Continue Reading
Moderna’s breakthrough highlights a broader transformation, as AI accelerates the clinical development of therapies at a pace that would have seemed unimaginable a few years ago. Continue Reading
A bond market selloff has pressured 60/40 investment portfolios, which have returned 8% on average this year compared with 13% for the S&P 500. Investors can look to healthcare stocks for relief. Continue Reading
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA [ht…
Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3% Continue Reading
The State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides broad exposure to the biotech industry, while the First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) offers a much more concentrated, equal-weighted alternative. Biotec…
Check out the companies making the biggest moves premarket: Moderna , Merck — Shares of the pharmaceutical companies surged after a personalized cancer vaccine between the two companies showed positive results in a late-stage trial . Moder…